Deleterious effects of plasminogen activators in neonatal cerebral hypoxia-ischemia

American Journal of Pathology

Volumn 172, Issue 6, 2008, Pages 1704-1716

  Adhami, Faisal ^a,b   Yu, Dan ^a,d   Yin, Wei ^c   Schloemer, Aryn ^a   Burns, Kevin A ^a   Liao, Guanghong ^a,e   Degen, Jay L ^a   Chen, Jun ^c   Kuan, Chia Yi ^a,f  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d SICHUAN UNIVERSITY   (China)

^e Western University of Health Sciences   (United States)

^f CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADOLESCENT; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN PERFUSION; CONTROLLED STUDY; ENZYME INDUCTION; IN SITU HYBRIDIZATION; MACROPHAGE; NEUROFILAMENT; NEUROPROTECTION; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOGENESIS; THROMBOSIS;

EID: 44849132907     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070979     Document Type: Article

References (36)

1. Ferriero DM: Neonatal brain injury. N Engl J Med 2004, 351:1985-1995
2. Rice JE III, Vannucci RC, Brierley JB: The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981, 19:131-141
3. McDonald JW, Silverstein FS, Cardona D, Hudson C, Chen R, Johnston MV: Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats. Neuroscience 1990, 36:589-599
4. Vannucci SJ, Hagberg H: Hypoxia-ischemia in the immature brain. J Exp Biol 2004, 207:3149-3154
5. Vexler ZS, Sharp FR, Feuerstein GZ, Ashwal S, Thoresen M, Yager JY, Ferriero DM: Translational stroke research in the developing brain. Pediatr Neurol 2006, 34:459-463
6. Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM: The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab 2004, 24:945-963
7. Tsuji K, Aoki T, Tejima E, Arai K, Lee SR, Atochin DN, Huang PL, Wang X, Montaner J, Lo EH: Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke 2005, 36:1954-1959
8. Sappino AP, Madani R, Huarte J, Belin D, Kiss JZ, Wohlwend A, Vassalli JD: Extracellular proteolysis in the adult murine brain. J Clin Invest 1993, 92:679-685
9. Tsirka SE, Gualandris A, Amaral DG, Strickland S: Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 1995, 377:340-344
10. Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S: An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 1997, 17:543-552
11. Junge CE, Sugawara T, Mannaioni G, Alagarsamy S, Conn PJ, Brat DJ, Chan PH, Traynelis SF: The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proc Natl Acad Sci USA 2003, 100:13019-13024
12. Siao CJ, Tsirka SE: Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. J Neurosci 2002, 22:3352-3358
13. Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, Vivien D, Buisson A: The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 2001, 7:59-64
14. Rosenberg GA, Navratil M, Barone F, Feuerstein G: Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 1996, 16:360-366
15. Ahn MY, Zhang ZG, Tsang W, Chopp M: Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice. Brain Res 1999, 837:169-176
16. Hosomi N, Lucero J, Heo JH, Koziol JA, Copeland BR, del Zoppo GJ: Rapid differential endogenous plasminogen activator expression after acute middle cerebral artery occlusion. Stroke 2001, 32:1341-1348
17. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA: Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 1998, 4:228-231
18. Nagai N, De Mol M, Lijnen HR, Carmeliet P, Collen D: Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. Circulation 1999, 99:2440-2444
19. Tabrizi P, Wang L, Seeds N, McComb JG, Yamada S, Griffin JH, Carmeliet P, Weiss MH, Zlokovic BV: Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. Arterioscler Thromb Vasc Biol 1999, 19:2801-2806
20. Nagai N, Zhao BQ, Suzuki Y, Ihara H, Urano T, Umemura K: Tissue-type plasminogen activator has paradoxical roles in focal cerebral ischemic injury by thrombotic middle cerebral artery occlusion with mild or severe photochemical damage in mice. J Cereb Blood Flow Metab 2002, 22:648-651
21. Mujsce DJ, Christensen MA, Vannucci RC: Cerebral blood flow and edema in perinatal hypoxic-ischemic brain damage. Pediatr Res 1990, 27:450-453
22. Adhami F, Liao G, Morozov YM, Schloemer A, Schmithorst VJ, Lorenz JN, Dunn RS, Vorhees CV, Wills-Karp M, Degen JL, Davis RJ, Mizushima N, Rakic P, Dardzinski BJ, Holland SK, Sharp FR, Kuan CY: Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. Am J Pathol 2006, 169:566-583
23. Yin W, Cao G, Johnnides MJ, Signore AP, Luo Y, Hickey RW, Chen J: TAT-mediated delivery of Bcl-xL protein is neuroprotective against neonatal hypoxic-ischemic brain injury via inhibition of caspases and AIF. Neurobiol Dis 2006, 21:358-371
24. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC: Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994, 368:419-424
25. Svedin P, Hagberg H, Savman K, Zhu C, Mallard C: Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci 2007, 27:1511-1518
26. Liot G, Benchenane K, Leveille F, Lopez-Atalaya JP, Fernandez-Monreal M, Ruocco A, Mackenzie ET, Buisson A, Ali C, Vivien D: 2,7-Bis-(4- amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo. J Cereb Blood Flow Metab 2004, 24:1153-1159
27. Vassalli JD, Belin D: Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett 1987, 214:187-191
28. El-Khoury N, Braun A, Hu F, Pandey M, Nedergaard M, Lagamma EF, Ballabh P: Astrocyte end-feet in germinal matrix, cerebral cortex, and white matter in developing infants. Pediatr Res 2006, 59:673-679
29. Lo EH, Broderick JP, Moskowitz MA: tPA and proteolysis in the neurovascular unit. Stroke 2004, 35:354-356
30. Melchor JP, Strickland S: Tissue plasminogen activator in central nervous system physiology and pathology. Thromb Haemost 2005, 93:655-660
31. Melchor JP, Pawlak R, Strickland S: The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. J Neurosci 2003, 23:8867-8871
32. Liu D, Cheng T, Guo H, Fernández JA, Griffin JH, Song X, Zlokovic BV: Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C. Nat Med 2004, 10:1379-1383
33. du Plessis AJ, Volpe JJ: Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol 2002, 15:151-157
34. Nagai N, Yamamoto S, Tsuboi T, Ihara H, Urano T, Takada Y, Terakawa S, Takada A: Tissue-type plasminogen activator is involved in the process of neuronal death induced by oxygen-glucose deprivation in culture. J Cereb Blood Flow Metab 2001, 21:631-634
35. Leroux P, Hennebert O, Legros H, Laudenbach V, Carmeliet P, Marret S: Role of tissue-plasminogen activator (t-PA) in a mouse model of neonatal white matter lesions: interaction with plasmin inhibitors and anti-inflammatory drugs. Neuroscience 2007, 146:670-678
36. Liu Y, Silverstein FS, Skoff R, Barks JD: Hypoxic-ischemic oligodendroglial injury in neonatal rat brain. Pediatr Res 2002, 51:25-33